Cargando…

Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer

BACKGROUND AND PURPOSE: There has been little success targeting individual genes in combination with radiation in head and neck cancer. In this study we investigated whether targeting two key pathways simultaneously might be more effective. MATERIALS AND METHODS: We studied the effect of combining d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilson, George D., Wilson, Thomas G., Hanna, Alaa, Dabjan, Mohamad, Buelow, Katie, Torma, John, Marples, Brian, Galoforo, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677653/ https://www.ncbi.nlm.nih.gov/pubmed/33251343 http://dx.doi.org/10.1016/j.ctro.2020.11.003

Ejemplares similares

Dual blockade of PI3K and MEK in combination with radiation in head and neck cancer
por: Blas, Kevin, et al.
Publicado: (2018)

Cancer Stem Cell Signaling during Repopulation in Head and Neck Cancer
por: Wilson, George D., et al.
Publicado: (2016)

Design, Synthesis and Phenotypic Profiling of Simplified Gedatolisib Analogues
por: Costa, Caroline Marques Xavier, et al.
Publicado: (2023)

Antitumor activity of the dual PI3K/mTOR inhibitor gedatolisib and the involvement of ABCB1 in gedatolisib resistance in canine tumor cells
por: Murase, Yusuke, et al.
Publicado: (2022)

Pre-Clinical Characterization of Dacomitinib (PF-00299804), an Irreversible Pan-ErbB Inhibitor, Combined with Ionizing Radiation for Head and Neck Squamous Cell Carcinoma
por: Williams, Justin P., et al.
Publicado: (2014)

Early Treatment Response Monitoring Using 2-Deoxy-2-[(18)F]fluoro-D-glucose Positron Emission Tomography Imaging during Fractionated Radiotherapy of Head Neck Cancer Xenografts
por: Huang, Jiayi, et al.
Publicado: (2014)

The Effect of Hepatic Impairment on the Pharmacokinetics of Dacomitinib
por: Piscitelli, Joseph, et al.
Publicado: (2022)

Dacomitinib, an Irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models That Exhibit Low Response to Cetuximab
por: Ather, Ferdows, et al.
Publicado: (2013)

Effects of dacomitinib on the pharmacokinetics of poziotinib in vivo and in vitro
por: Ji, Weiping, et al.
Publicado: (2021)

Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck
por: Cook, Maclean M., et al.
Publicado: (2020)

ABCB1 and ABCG2 restricts the efficacy of gedatolisib (PF-05212384), a PI3K inhibitor in colorectal cancer cells
por: Liu, Changfu, et al.
Publicado: (2021)

Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer
por: Tamura, Shuzo, et al.
Publicado: (2018)

Localization and Accumulation Studies of Dacomitinib in Rat Intestines and Skin by Immunohistochemistry
por: Yamamoto, Yutaro, et al.
Publicado: (2019)

Efficacy of dacomitinib in patients with EGFR‐mutated NSCLC and brain metastases
por: Zhang, Jinyao, et al.
Publicado: (2021)

Tumor growth inhibition modeling to support the starting dose for dacomitinib
por: Fostvedt, Luke K., et al.
Publicado: (2022)

Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models
por: Langdon, Simon P., et al.
Publicado: (2019)

Dacomitinib improves chemosensitivity of cisplatin-resistant human ovarian cancer cells
por: Xu, Lei, et al.
Publicado: (2021)

Drug-induced liver injury associated with dacomitinib: A case report
por: Wang, Xuanxuan, et al.
Publicado: (2022)

Radiation-induced neuropathies in head and neck cancer: prevention and treatment modalities
por: Azzam, Patrick, et al.
Publicado: (2020)

The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings
por: Shor, Ryann E., et al.
Publicado: (2021)

Dramatic Response of Brain Metastasis from EGFR-mutation-positive NSCLC to Dacomitinib
por: Kudo, Kenichiro, et al.
Publicado: (2020)

Radiation therapy in head and neck cancer
por: Alfouzan, Afnan F.
Publicado: (2021)

Plasma exchange treats severe intrahepatic cholestasis caused by dacomitinib: A case report
por: Qiao, Fei, et al.
Publicado: (2022)

Histomorphological and Immunohistochemical Study of Dacomitinib-Induced Ileal Mucositis in Rats with the Possible Protection by Baicalin
por: Kandeel, Samah, et al.
Publicado: (2022)

Imaging of the Head and Neck following Radiation Treatment
por: Debnam, J. Matthew
Publicado: (2011)

Radiation Therapy in the Treatment of Head and Neck Rhabdomyosarcoma
por: Frankart, Andrew J., et al.
Publicado: (2021)

Magnetic Resonance-Guided Radiation Therapy for Head and Neck Cancers
por: Lavigne, Danny, et al.
Publicado: (2022)

Radiation-Induced Sarcomas of the Head and Neck: A Systematic Review
por: Coca-Pelaz, Andrés, et al.
Publicado: (2020)

Setup uncertainties for inter-fractional head and neck cancer in radiotherapy
por: Park, Eun-Tae, et al.
Publicado: (2016)

Planned Neck Dissection Following Radiation Treatment for Head and Neck Malignancy
por: Dautremont, J. F., et al.
Publicado: (2012)

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors
por: Endersby, Raelene, et al.
Publicado: (2018)

Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib
por: Zugazagoitia, Jon, et al.
Publicado: (2017)

Radiation-induced sarcomas of the head and neck in post-radiation nasopharyngeal carcinoma
por: Yang, Qiuxia, et al.
Publicado: (2016)

Intraoperative radiation therapy for locally advanced and recurrent head and neck cancer
por: Chiodo, Celina, et al.
Publicado: (2022)

Palliative Hypo-fractionated Radiotherapy in Locally Advanced Head and Neck Cancer with Fixed Neck Nodes
por: Paliwal, Rajan, et al.
Publicado: (2012)

Intensity modulated radiation therapy for head and neck cancer /
Publicado: (2003)

Acute radiation toxicity in head and neck and lung malignancies
por: Laskar, Sarbani Ghosh, et al.
Publicado: (2014)

Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck
por: Rodriguez-Russo, Carlos A., et al.
Publicado: (2021)

Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells
por: McDermott, N., et al.
Publicado: (2016)

Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation
por: Awwad, H K, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_4k35jvnb261im4e610l8s80il5